Literature DB >> 16867975

Low absolute neutrophil counts in African infants.

Athena P Kourtis1, Brian Bramson, Charles van der Horst, Peter Kazembe, Yusuf Ahmed, Charles Chasela, Mina Hosseinipour, Rodney Knight, Lebah Lugalia, Gerald Tegha, George Joaki, Robert Jafali, Denise J Jamieson.   

Abstract

Infants of African origin have a lower normal range of absolute neutrophil counts than white infants; this fact, however, remains under appreciated by clinical researchers in the United States. During the initial stages of a clinical trial in Malawi, the authors noted an unexpectedly high number of infants with absolute neutrophil counts that would be classifiable as neutropenic using the National Institutes of Health's Division of AIDS toxicity tables. The authors argue that the relevant Division of AIDS table does not take into account the available evidence of low absolute neutrophil counts in African infants and that a systematic collection of data from many African settings might help establish the absolute neutrophil count cutpoints to be used for defining neutropenia in African populations.

Entities:  

Mesh:

Year:  2005        PMID: 16867975     DOI: 10.1177/1545109705282591

Source DB:  PubMed          Journal:  J Int Assoc Physicians AIDS Care (Chic)        ISSN: 1545-1097


  11 in total

1.  Modifications of a large HIV prevention clinical trial to fit changing realities: a case study of the Breastfeeding, Antiretroviral, and Nutrition (BAN) protocol in Lilongwe, Malawi.

Authors:  Charles van der Horst; Charles Chasela; Yusuf Ahmed; Irving Hoffman; Mina Hosseinipour; Rodney Knight; Susan Fiscus; Michael Hudgens; Peter Kazembe; Margaret Bentley; Linda Adair; Ellen Piwoz; Francis Martinson; Ann Duerr; Athena Kourtis; A Edde Loeliger; Beth Tohill; Sascha Ellington; Denise Jamieson
Journal:  Contemp Clin Trials       Date:  2008-09-07       Impact factor: 2.226

2.  Impact of genetic polymorphisms determining leukocyte/neutrophil count on chemotherapy toxicity.

Authors:  S J Glisovic; Y D Pastore; V Gagne; M Plesa; C Laverdière; J M Leclerc; D Sinnett; M Krajinovic
Journal:  Pharmacogenomics J       Date:  2017-05-23       Impact factor: 3.550

3.  Extended prophylaxis with nevirapine and cotrimoxazole among HIV-exposed uninfected infants is well tolerated.

Authors:  Jim Aizire; Mary Glenn Fowler; Jing Wang; Avinash K Shetty; Lynda Stranix-Chibanda; Moreen Kamateeka; Elizabeth R Brown; Steve G Bolton; Philippa M Musoke; Hoosen Coovadia
Journal:  AIDS       Date:  2012-01-28       Impact factor: 4.177

4.  Considerations in using US-based laboratory toxicity tables to evaluate laboratory toxicities among healthy malawian and Ugandan infants.

Authors:  Irene R Lubega; Mary Glenn Fowler; Philippa M Musoke; Ali Elbireer; Danstan Bagenda; George Kafulafula; Jeanne Ko; Linda Mipando; Mike Mubiru; Newton Kumwenda; Taha Taha; J Brooks Jackson; Laura Guay
Journal:  J Acquir Immune Defic Syndr       Date:  2010-09       Impact factor: 3.731

5.  Maternal or infant antiretroviral drugs to reduce HIV-1 transmission.

Authors:  Charles S Chasela; Michael G Hudgens; Denise J Jamieson; Dumbani Kayira; Mina C Hosseinipour; Athena P Kourtis; Francis Martinson; Gerald Tegha; Rodney J Knight; Yusuf I Ahmed; Deborah D Kamwendo; Irving F Hoffman; Sascha R Ellington; Zebrone Kacheche; Alice Soko; Jeffrey B Wiener; Susan A Fiscus; Peter Kazembe; Innocent A Mofolo; Maggie Chigwenembe; Dorothy S Sichali; Charles M van der Horst
Journal:  N Engl J Med       Date:  2010-06-17       Impact factor: 91.245

6.  Effect of co-trimoxazole on mortality in HIV-exposed but uninfected children in Botswana (the Mpepu Study): a double-blind, randomised, placebo-controlled trial.

Authors:  Shahin Lockman; Michael Hughes; Kate Powis; Gbolahan Ajibola; Kara Bennett; Sikhulile Moyo; Erik van Widenfelt; Jean Leidner; Kenneth McIntosh; Loeto Mazhani; Joseph Makhema; Max Essex; Roger Shapiro
Journal:  Lancet Glob Health       Date:  2017-05       Impact factor: 26.763

7.  Health outcomes of HIV-exposed uninfected African infants.

Authors:  Athena P Kourtis; Jeffrey Wiener; Dumbani Kayira; Charles Chasela; Sascha R Ellington; Lisa Hyde; Mina Hosseinipour; Charles van der Horst; Denise J Jamieson
Journal:  AIDS       Date:  2013-03-13       Impact factor: 4.177

8.  Neutrophil count in African mothers and newborns and HIV transmission risk.

Authors:  Athena P Kourtis; Michael G Hudgens; Dumbani Kayira
Journal:  N Engl J Med       Date:  2012-12-06       Impact factor: 91.245

9.  Cotrimoxazole prophylaxis and risk of severe anemia or severe neutropenia in HAART-exposed, HIV-uninfected infants.

Authors:  Scott Dryden-Peterson; Oluwemimo Jayeoba; Michael D Hughes; Haruna Jibril; Kenneth McIntosh; Taolo A Modise; Aida Asmelash; Kathleen M Powis; Max Essex; Roger L Shapiro; Shahin Lockman
Journal:  PLoS One       Date:  2013-09-23       Impact factor: 3.240

10.  Pharmacokinetics and safety of rifabutin in young HIV-infected children receiving rifabutin and lopinavir/ritonavir.

Authors:  Harry Moultrie; Helen McIlleron; Shobna Sawry; Tracy Kellermann; Lubbe Wiesner; Gurpreet Kindra; Hermien Gous; Annelies Van Rie
Journal:  J Antimicrob Chemother       Date:  2014-10-03       Impact factor: 5.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.